Clinical trial · Interventional
A Randomized Multicenter Study of Daylight Mediated Photodynamic Therapy (PDT)
NCT00711178CI-TRIAL-00004077completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
A randomised, multi-center study of daylight mediated photodynamic therapy (PDT) with Metvix in patients with multiple actinic keratosis on the face and/or scalp.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Actinic Keratoses | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Photodynamic therapy with methyl aminolevulinate | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- A
- description
- 2 hours sunlight
- interventionNames
- Procedure: Photodynamic therapy with methyl aminolevulinate
- type
- ACTIVE_COMPARATOR
- label
- B
- description
- 3 hours of sunlight
- interventionNames
- Procedure: Photodynamic therapy with methyl aminolevulinate
Primary outcomes (1)
- measure
- response rate
- timeFrame
- 3 months
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * 18 years and older, 5 AK in face and scalp Exclusion Criteria: * immunosuppression
References
Publications (0)
Data not yet available
No reference posted for this study.